New cancer clinical trial: Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

Published on: January 30, 2019 at 12:00PM
Condition:   Breast Cancer
Interventions:   Drug: Ribociclib;   Drug: Letrozole or Anastrozole;   Drug: Goserelin
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting
http://bit.ly/2CWU8RK